Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial

References

• Marquie C, De Geeter G, Klug D, Kouakam C, Brigadeau F, Jabourek O, et al. Post-operative use of heparin increases morbidity of pacemaker implantation. Europace. 2006;8:283–7.
   PubMed Web of Science ®Google Scholar
• Giudici MC, Paul DL, Bontu P, Barold SS. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol. 2004;27:358–60.
   PubMed Web of Science ®Google Scholar
• Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e326S–50S.
   Web of Science ®Google Scholar
• Ahmed I, Gertner E, Nelson WB, House CM, Dahiya R, Anderson CP, et al. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm. 2010;7:745–9.
   PubMed Web of Science ®Google Scholar
• Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, et al. Dual antiplatelet therapy and heparin “bridging” significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol. 2010;55:2376–82.
   PubMed Web of Science ®Google Scholar
• Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, et al. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009;32: 378–82.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368:2084–93.
   PubMed Web of Science ®Google Scholar
• Airaksinen KE, Korkeila P, Lund J, Ylitalo A, Karjalainen P, Virtanen V, et al. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment - The FinPAC study. Int J Cardiol. 2013;168:3679–82.
   PubMed Web of Science ®Google Scholar
• Karjalainen P, Vikman S, Niemelä M, Porela P, Ylitalo A, Vaittinen M, et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J. 2008;29:1001–10.
   PubMed Web of Science ®Google Scholar
• Annala AP, Karjalainen PP, Biancari F, Niemelä M, Ylitalo A, Vikman S, et al. Long-term safety of drug-eluting stents in patients on warfarin treatment. Ann Med. 2012;44:271–8.
   PubMed Web of Science ®Google Scholar
• Korkeila P, Ylitalo A, Koistinen J, Airaksinen K. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: a prospective serial venographic study. Ann Med. 2009;41:216–23.
   PubMed Web of Science ®Google Scholar
• Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011;8:1114–54.
   PubMed Web of Science ®Google Scholar
• Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126:1177–86.
   PubMed Web of Science ®Google Scholar
• Cheng M, Hua W, Chen K, Pu J, Ren X, Zhao X, et al. Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation. Europace. 2009;11:1183–7.
   PubMed Web of Science ®Google Scholar
• Tolosana JM, Berne P, Mont L, Heras M, Berruezo A, Monteagudo J, et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin?A prospective randomized trial. Eur Heart J. 2009;30:1880–4.
   PubMed Web of Science ®Google Scholar
• Airaksinen K, Schlitt A, Rubboli A, Karjalainen P, Lip G. How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to “bridge” or not to “bridge”?EuroIntervention. 2010;6:520–6.
   PubMed Web of Science ®Google Scholar
• Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low- molecular weight heparin. Am Heart J. 2009;158:252–6.
   PubMed Web of Science ®Google Scholar
• Jamula E, Douketis JD, Schulman S. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost. 2008;6:1615–21.
   PubMed Web of Science ®Google Scholar
• Cheng A, Nazarian S, Brinker JA, Tompkins C, Spragg DD, Leng CT, et al. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial. Heart Rhythm. 2011;8:536–40.
   PubMed Web of Science ®Google Scholar
• Przybylski A, Derejko P, Kwaśniewski W, Urbańczyk-Swić D, Zakrzewska J, Orszulak W, et al. Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: results of a prospective, two-centre registry. Neth Heart J. 2010;18:230–5.
   PubMed Web of Science ®Google Scholar
• Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. Europace. 2010;12:103–8.
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010; 122:1553–61.
   PubMed Web of Science ®Google Scholar
• Kutinsky IB, Jarandilla R, Jewett M, Haines DE. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol. 2010;3:312–18.
   PubMed Web of Science ®Google Scholar